Highbridge Capital Management’s Immunogen Inc IMGN Stock Holding History

Highbridge Capital Management’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-200,000	Closed	-$5.93M	–	363
2023 Q4	$5.93M	Buy	+200,000	New	+$3.98M	0.24%	75
2018 Q1	–	Sell	-109,863	Closed	-$704K	–	1826
2017 Q4	$704K	Buy	+109,863	New	+$678K	0.01%	722
2015 Q3	–	Sell	-128,255	Closed	-$1.84M	–	1882
2015 Q2	$1.84M	Buy	+128,255	New	+$1.41M	0.02%	549
2014 Q3	–	Sell	-64,190	Closed	-$761K	–	1414
2014 Q2	$761K	Buy	+64,190	New	+$806K	0.01%	634

Other funds holding IMGN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Highbridge Capital Management's IMGN Position: Q1 2024 in Review

Highbridge Capital Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 200,000 shares — an estimated $5.93M sold.

Highbridge Capital Management first reported a position in IMGN in Q2 2014 and held it in 4 quarters. The position peaked at $5.93M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

Highbridge Capital Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
Highbridge Capital Management sold 200,000 Immunogen Inc shares in Q1 2024, an estimated $5.93M.
Highbridge Capital Management first reported a position in Immunogen Inc in Q2 2014 and held it in 4 quarters.
Highbridge Capital Management's Immunogen Inc position peaked at $5.93M in Q4 2023.
3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Highbridge Capital Management's 13F filing for Q1 2024, filed 10 May 2024.